Valuation APTOCROM Inc.

Stocks

End-of-day quote Korea S.E. 21/10/2026			5-day change	1st Jan Change
1,872.00 ^KRW	+1.03%		-0.95%	-62.56%

09-22	Aprogen Medicines Inc. announced that it has received KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc.	CI
09-03	Aprogen Medicines Inc. announced that it expects to receive KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	132,471	125,151	66,950	51,548	104,593	55,188
Change	-	-5.53%	-46.5%	-23.01%	102.9%	-47.23%
Enterprise Value (EV) ¹	101,306	69,004	-14,380	55,057	79,526	37,996
Change	-	-31.89%	-120.84%	482.87%	44.44%	-52.22%
P/E	12x	47.2x	-11.9x	24x	-2.12x	-9.5x
PBR	0.57x	0.56x	0.34x	0.31x	0.35x	0.18x
PEG	-	-0.6x	0x	-0x	0x	0.1x
Capitalization / Revenue	12.8x	14.9x	6.98x	3.22x	6.38x	5.63x
EV / Revenue	9.82x	8.2x	-1.5x	3.44x	4.85x	3.87x
EV / EBITDA	4,671x	-31.8x	1.22x	-2.69x	83.9x	-2.32x
EV / EBIT	-270x	-26.8x	1.19x	-2.62x	154x	-2.27x
EV / FCF	-1.98x	5.77x	-0.46x	13.1x	-32.9x	-1.9x
FCF Yield	-50.6%	17.3%	-216%	7.65%	-3.04%	-52.7%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	6,200	1,484	-3,140	648.5	-4,924	-526.5
Distribution rate	-	-	-	-	-	-
Net sales ¹	10,319	8,416	9,598	16,007	16,400	9,807
EBITDA ¹	21.69	-2,167	-11,810	-20,454	947.7	-16,372
EBIT ¹	-375.2	-2,579	-12,099	-21,004	517.3	-16,737
Net income ¹	11,084	2,650	-5,607	4,304	-28,094	-5,559
Net Debt ¹	-31,165	-56,147	-81,330	3,509	-25,067	-17,192
Reference price ²	74,200.00	70,100.00	37,500.00	15,580.00	10,420.00	5,000.00
Nbr of stocks (in thousands)	1,785	1,785	1,785	3,309	10,038	11,038
Announcement Date	15/03/21	14/03/22	17/03/23	13/03/24	14/03/25	20/03/26

¹KRW in Million²KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
APTOCROM INC.	-	-	-	-	21.11M
ELI LILLY AND COMPANY	36.99x	13.22x	28x	0.53%	1,144B
JOHNSON & JOHNSON	37.96x	6.39x	17.99x	2.06%	625B
ABBVIE INC.	36.9x	8.47x	17.49x	2.38%	511B
ROCHE HOLDING AG	21.13x	5.1x	12.68x	2.57%	377B
MERCK & CO., INC.	108.1x	6.04x	25.89x	2.3%	366B
NOVARTIS AG	21.5x	5.61x	13.79x	2.85%	291B
ASTRAZENECA PLC	22.06x	4.46x	12.76x	1.98%	262B
AMGEN INC.	27.87x	7.15x	12.8x	2.3%	237B
GILEAD SCIENCES, INC.	-45.73x	7.01x	27.13x	2.11%	194B
Average	29.64x	7.05x	18.73x	2.12%	400.79B
Weighted average by Cap.	35.48x	8.34x	20.49x	1.8%